Skip to content
ATLAS REFERENCE / EVIDENCE BEFORE ASSUMPTIONS
Atlas Formulations
ATLAS / EDUCATIONAL REFERENCE

Peptide &
Compound Library.

Explore the science. Separate human findings from preclinical signals, and see what the evidence leaves unanswered.

Educational reference, separate from the shop. Inclusion does not imply Atlas sells a compound or endorses its use. No medical advice, dosing, or administration guidance.
How to read the evidence labels

Human evidence: selected controlled clinical research or its systematic review, not an endorsement. Primarily preclinical: mostly animal or laboratory findings. Mixed / limited human: different study types, with small or narrowly focused human studies. These labels describe the cited evidence, not regulatory status or a ranking of compounds.

8 profiles

Metabolism

Semaglutide

A GLP-1 analogue with randomized human evidence; trial outcomes remain specific to the studied population and formulation.

Human evidenceRead evidence profile
Metabolism

Retatrutide

A triple-receptor agonist with published phase 2 human research; this entry describes that study, not current approval status.

Human evidenceRead evidence profile
Tissue biology

BPC-157

A gastric-peptide research topic with predominantly animal evidence and major gaps in reliable human safety data.

Primarily preclinicalRead evidence profile
Tissue biology

GHK-Cu

A copper-binding tripeptide studied in cell, animal, and cosmetic contexts; those evidence types are not interchangeable.

Mixed / limited humanRead evidence profile
Metabolism

MOTS-c

A mitochondrial-derived peptide investigated in metabolic signalling; the foundational intervention findings are from mice.

Primarily preclinicalRead evidence profile